Valuation: Chongqing Jiheng Pharmaceutical Co., Ltd.

Market Cap 2.85B 424M 374M 354M 320M 602M 40.68B 610M 4.24B 1.63B 20.8B 1.59B 1.56B 66.67B P/E 2024
-2.74x
P/E 2025 -7.41x
Enterprise Value 3.26B 486M 428M 405M 366M 689M 46.56B 698M 4.85B 1.87B 23.8B 1.82B 1.78B 76.32B EV / Sales 2024
2.87x
EV / Sales 2025 3.89x
Free-Float
54.4%
Yield 2024 *
-
Yield 2025 -
08-14 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
04-24 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-30 Chongqing Sansheng Industrial Co.,Ltd. agreed to acquire an additional 11.94% stake in Chongqing Chunrui Pharmaceutical and Chemical Co., Ltd. from Hao Tingyan. CI
03-16 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
28/10/25 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
26/08/25 Chongqing Jiheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
04/07/25 Zhang Yanning and Cen Yetao completed the acquisition of 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
02/07/25 Zhang Yanning and Cen Yetao agreed to acquire 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
02/07/25 Zhang Yanning and Cen Yetao agreed to acquire 7.45% stake in Chongqing Sansheng Industrial Co.,Ltd. from Pan Xianwen for approximately CNY 110 million. CI
25/04/25 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25/04/25 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25/04/25 Chongqing Sansheng Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt CI
29/10/24 Chongqing Sansheng Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
1 day+1.46%
1 week-1.19%
1 month-25.98%
3 months+24.18%
6 months-6.94%
Current year-7.96%
1 week 4.05
Extreme 4.05
4.2
1 month 3.94
Extreme 3.94
5.32
Current year 3.18
Extreme 3.18
6.24
1 year 3.18
Extreme 3.18
6.24
3 years 1.24
Extreme 1.24
6.24
5 years 1.24
Extreme 1.24
7.83
10 years 1.24
Extreme 1.24
31.05
Manager TitleAgeSince
Chief Executive Officer 59 01/03/2010
Director of Finance/CFO 52 21/04/2023
Chief Tech/Sci/R&D Officer 49 -
Director TitleAgeSince
Director/Board Member 54 27/09/2019
Director/Board Member 74 -
Director/Board Member 69 27/09/2019
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%-1.19%-12.05%+8.62% 424M
-2.33%+0.53%+51.65%+115.42% 1,031B
-1.06%-1.65%+42.78%+69.98% 638B
-0.65%-1.32%+12.98%+75.49% 462B
-2.66%-1.87%+73.13%+41.15% 359B
-0.06%-3.88%+34.32%+39.39% 335B
-0.79%+2.01%+19.82%+27.79% 273B
-1.19%-1.21%+9.82%+10.61% 253B
-0.50%+3.80%+49.37%+56.84% 228B
-1.47%-1.53%+34.28%+98.89% 185B
Average -0.61%-0.45%+31.61%+54.42% 376.43B
Weighted average by Cap. -1.01%-0.35%+39.78%+71.20%

Financials

2024 2025
Net sales 1.2B 178M 157M 149M 134M 253M 17.09B 256M 1.78B 685M 8.74B 669M 655M 28.01B 900M 134M 118M 112M 101M 190M 12.86B 193M 1.34B 515M 6.58B 504M 493M 21.08B
Net income -650M -96.92M -85.35M -80.87M -73M -138M -9.29B -139M -968M -372M -4.75B -364M -356M -15.23B -420M -62.57M -55.1M -52.2M -47.13M -88.82M -6B -89.97M -625M -240M -3.07B -235M -230M -9.83B
Net Debt 1.66B 248M 218M 207M 187M 352M 23.75B 356M 2.47B 951M 12.14B 930M 910M 38.92B 412M 61.36M 54.04M 51.2M 46.22M 87.11M 5.88B 88.24M 613M 236M 3.01B 230M 225M 9.64B
Logo Chongqing Jiheng Pharmaceutical Co., Ltd.
Chongqing Jiheng Pharmaceutical Co Ltd, formerly Chongqing Sansheng Industrial Co Ltd is a China-based company primarily engaged in building materials and chemical, and pharmaceutical manufacturing businesses. The Company operates two main businesses. The building materials and chemical business is primarily engaged in the production and sales of ready-mixed concrete, water-reducing agents, expanding agents and sulfuric acid. The pharmaceutical manufacturing business is primarily engaged in the production and sales of pharmaceutical intermediates such as procaine hydrochloride and cefoxitin intermediates, active pharmaceutical ingredients (APIs) such as acetaminophen and clopidogrel hydrochloride, and pharmaceutical preparations such as compound acetaminophen and diphenhydramine tablets, and clopidogrel hydrochloride tablets. The Company conducts its businesses in the domestic market and overseas markets.
Employees
979
Date Price Change Volume
30/09/26 CN¥4.160 +1.46% 19,961,900
29/09/26 CN¥4.100 -.--% 13,298,550
28/09/26 CN¥4.100 -0.97% 16,290,100
24/09/26 CN¥4.140 -1.66% 19,134,501
23/09/26 CN¥4.210 -3.44% 27,202,100
  1. Stock Market
  2. Stocks
  3. 002742 Stock